Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2100027	注射用人干扰素γ	Human Interferon γ	Lyophilized	Biological Products(2.2)	New Drug Application	2021-03-02	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	In Review	2021-03-01	view
CXSS2100026	注射用人干扰素γ	Human Interferon γ	Lyophilized	Biological Products(2.2)	New Drug Application	2021-03-02	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	In Review	2021-03-01	view
CXSS2100029	注射用人干扰素γ	Human Interferon γ	Lyophilized	Biological Products(3.2)	New Drug Application	2021-03-02	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	In Review	2021-03-01	view
CXSS2100028	注射用人干扰素γ	Human Interferon γ	Lyophilized	Biological Products(3.2)	New Drug Application	2021-03-02	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	In Review	2021-03-01	view
CYSB1900396	注射用重组人干扰素γ	Human Interferon γ	Lyophilized	Biological Products	Supplementary Application	2019-12-05	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	Certificate Issued	2020-02-14	view
CYSB1900397	注射用重组人干扰素γ	Human Interferon γ	Lyophilized	Biological Products	Supplementary Application	2019-12-05	上海凯茂生物医药有限公司	Shanghai Chemo Wanbang Biophama Co Ltd	Certificate Issued	2020-02-14	view
CSS01025	注射用重组人干扰素Y	Human Interferon γ	Lyophilized	Biological Products(5)	New Drug Application	2001-06-27	上海克隆生物高技术有限公司	Shanghai Clonbiotech Co Ltd	Certificate Issued	2002-07-10	view